Copyright
©The Author(s) 2022.
World J Dermatol. Sep 2, 2022; 10(2): 10-16
Published online Sep 2, 2022. doi: 10.5314/wjd.v10.i2.10
Published online Sep 2, 2022. doi: 10.5314/wjd.v10.i2.10
Parameter | Result | Reference range (units) |
Random blood sugar | 139 | 70.2-140.5 (mg/dL) |
Renal function test | ||
Urea | 34 | 17.0-50.0 (mg/dL) |
Creatinine | 0.66 | 0.50-0.90 (mg/dL) |
Sodium | 139.3 | 136.0-145 (mmol/L) |
Potassium | 4.23 | 3.40-5.10 (mmol/L) |
Magnesium | 0.87 | 0.66-1.07 (mmol/L) |
Liver function test | ||
Bilirubin, total | 3.80 | 3.40-20.50 (μmol/L) |
Bilirubin, conjugated | 1.90 | 0.00-9.00 (μmol/L) |
Alanine aminotransferase | 10 | 5-55 (U/L) |
Aspartate aminotransferase | 12 | 5-34 (U/L) |
Total protein | 7.21 | 6.60-8.70 (g/dL) |
Albumin | 4.40 | 3.50-5.20 (g/dL) |
Alkaline phosphatase | 69 | 40-150 (U/L) |
Lactate dehydrogenase | 190 | 125-220 (U/L) |
Creatinine kinase | 16.180 | 20-180 (U/L) |
Vitamin D (25-OH) | 50 | > 30.0-70.0 (ng/mL) |
Calcium | 9.74 | 8.40-10.20 (mg/dL) |
- Citation: Aly MH, Alshehri AA, Mohammed A, Almaghrabi MA, Alharbi MM. Connection between dermatomyositis and montelukast sodium use: A case report. World J Dermatol 2022; 10(2): 10-16
- URL: https://www.wjgnet.com/2218-6190/full/v10/i2/10.htm
- DOI: https://dx.doi.org/10.5314/wjd.v10.i2.10